Phase 1 First-in-human Study of JS014

Authors
Category Primary study
Registry of Trialsclinicaltrials.gov
Year 2022
This phase 1, first-in-human study uses a BOIN design to assess the safety and potential efficacy of JS014 at different dose levels as a single agent and in combination with fixed dose of pembrolizumab in subjects with advanced cancer.
Epistemonikos ID: 146d84700ef45c2bfdf4ad8edffeb9e85dc8538f
First added on: May 10, 2024